Sugemalimab: clinical trials recruiting now
3
Recruiting trials
4
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 1 1
Phase 2 2
Phase 3 2
Conditions being studied
| Condition | Trials |
|---|---|
| Lung Cancer · Sugemalimab for Lung Cancer | 3 |
| Extensive-stage Small-cell Lung Cancer | 1 |
| Limited Stage Small Cell Lung Cancer | 1 |
| NSCLC (Non-small Cell Lung Cancer) | 1 |
Recruiting trials involving Sugemalimab
- A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLC
- Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC
- Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT
Common questions
How many recruiting trials involve Sugemalimab?
3 recruiting trials across 4 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.